RemSleep Holdings (RMSL) Beginning Cash Balance (2023)
RemSleep Holdings recorded quarterly Beginning Cash Balance of $79191.0 in Q2 2023, down 24.39% quarter-over-quarter from $104740.0 in Q1 2023.
RemSleep Holdings' Beginning Cash Balance history runs 1 years deep, the most recent figure standing at $79191.0 for Q2 2023.
- In Q2 2023, Beginning Cash Balance changed N/A year-over-year to $79191.0; the TTM figure through Dec 2023 stood at $183931.0 (changed N/A YoY), while the FY2023 annual figure was $183931.0, changed N/A from the prior year.
- Beginning Cash Balance came in at $79191.0 for Q2 2023 at RemSleep Holdings, down from $104740.0 in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $104740.0 in Q1 2023 to a low of $79191.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 79,191.00 |
| Jun 30, 2023 | 79,191.00 |
| Mar 31, 2023 | 104,740.00 |
| Mar 31, 2023 | 104,740.00 |